GGrantIndex
Sort

23,748 grants matching melanoma

TRIPTYCENE ANALOGS--NOVEL BIFUNCTIONAL ANTICANCER DRUGS

$196,425
Kansas State University · R01 · FY2000 · CA

A multimodal approach to develop molecular markers to predict response to immune targeted agents in non-small cell lung cancer

$196,414
Jeffrey C Thompson · University Of Pennsylvania · K08 · FY2021 · CA

A multimodal approach to develop molecular markers to predict response to immune targeted agents in non-small cell lung cancer

$196,414
Jeffrey C Thompson · University Of Pennsylvania · K08 · FY2022 · CA

A multimodal approach to develop molecular markers to predict response to immune targeted agents in non-small cell lung cancer

$196,414
Jeffrey C Thompson · University Of Pennsylvania · K08 · FY2018 · CA

A multimodal approach to develop molecular markers to predict response to immune targeted agents in non-small cell lung cancer

$196,414
Jeffrey C Thompson · University Of Pennsylvania · K08 · FY2020 · CA

A multimodal approach to develop molecular markers to predict response to immune targeted agents in non-small cell lung cancer

$196,414
Jeffrey C Thompson · University Of Pennsylvania · K08 · FY2019 · CA

Using MC1R genotype to impact skin cancer risk behaviors in Hispanics/Latinos

$196,295
Peter A Kanetsky · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2017 · CA

Role of senescent fibroblasts in UVB-induced carcinogenesis

$196,272
Dan F Spandau · Indiana University Indianapolis · R21 · FY2009 · CA

Pre-clinical Translation of Regulatory T-cell Inhibition in Brain Tumors

$196,250
John H Sampson · Duke University · R21 · FY2011 · NS

Regulation of PD-1 as a strategy against chronic HIV-1 infection

$196,250
Li Huang · Duke University · R21 · FY2014 · AI

CORE--CLINICAL AND MOLECULAR EPIDEMIOLOGY

$196,218
University Of Texas Md Anderson Can Ctr · P01 · FY2002 · CA

REGULATION AND INDUCTION OF APOPTOSIS IN SKIN CANCER

$196,218
University Of Texas Md Anderson Can Ctr · P01 · FY2001 · CA

CORE--CLINICAL AND MOLECULAR EPIDEMIOLOGY

$196,218
University Of Texas Md Anderson Can Ctr · P01 · FY2001 · CA

REGULATION AND INDUCTION OF APOPTOSIS IN SKIN CANCER

$196,218
University Of Texas Md Anderson Can Ctr · P01 · FY2002 · CA

CORE--BIOSAMPLE REPOSITORY

$196,218
Fox Chase Cancer Center · P30 · FY2002 · CA

SALICYLIHALAMIDES--CHEMISTRY AND BIOLOGY

$196,176
University Of Kansas Lawrence · R01 · FY2000 · CA

MARSHALL U COBRE: B-CATENIN FUNCTION AND RETINOIC ACID IN MELANOMA

$196,176
Beverly C Delidow · Marshall University · P20 · FY2007 · RR

SOUTHWEST ONCOLOGY GROUP

$196,154
University Of Michigan At Ann Arbor · U10 · FY2000 · CA

TERT transcriptional deregulation in thyroid cancer progression

$196,150
Inigo Landa-Lopez · Brigham And Women'S Hospital · K22 · FY2020 · CA

Novel method for spatial, multi-omic visualization of single-cell heterogeneity

$196,129
Dmitry N Derkach · Biosyntagma, Llc · R43 · FY2018 · CA

IL-12 GENE THERAPY TO PRIME AND REPOLARIZE ANTI-TUMOR TH1-TYPE T CELLS

$196,095
Walter J Storkus · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA

DEVELOPMENT/FUNCTION OF CD8 T CELLS TO SKIN ANTIGENS

$196,085
Cleveland Clinic Foundation · R01 · FY2000 · AR

Investigating Transcriptional Elongation and Nuclear RNA Surveillance in Melanoma

$195,902
Megan Leigh Insco · Dana-Farber Cancer Inst · K08 · FY2022 · CA

Investigating Transcriptional Elongation and Nuclear RNA Surveillance in Melanoma

$195,902
Megan Leigh Insco · Dana-Farber Cancer Inst · K08 · FY2025 · CA

Investigating Transcriptional Elongation and Nuclear RNA Surveillance in Melanoma

$195,902
Megan Leigh Insco · Dana-Farber Cancer Inst · K08 · FY2024 · CA